rs17421627
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The ENST00000787113.1(MIR9-2HG):n.130A>C variant causes a non coding transcript exon change. The variant allele was found at a frequency of 0.0495 in 152,284 control chromosomes in the GnomAD database, including 256 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.050 ( 256 hom., cov: 32)
Consequence
MIR9-2HG
ENST00000787113.1 non_coding_transcript_exon
ENST00000787113.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 6.45
Publications
30 publications found
Genes affected
MIR9-2HG (HGNC:42810): (MIR9-2 host gene) This is an evolutionarily conserved gene that produces alternatively spliced long non-coding RNAs that may be expressed predominantly in the brain and visual cortex. These transcripts may be involved in tumorigenesis, as depletion by siRNA suppressed glioma cell division. Transcripts may also bind to and regulate the activity of miR-411-5p and argonaut 2, thereby altering the expression of genes involved in tumor growth. [provided by RefSeq, Nov 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0702 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MIR9-2HG | ENST00000787113.1 | n.130A>C | non_coding_transcript_exon_variant | Exon 1 of 3 | ||||||
| MIR9-2HG | ENST00000502301.6 | n.218-9698A>C | intron_variant | Intron 3 of 4 | 4 | |||||
| MIR9-2HG | ENST00000504034.3 | n.166-9698A>C | intron_variant | Intron 1 of 7 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0495 AC: 7539AN: 152166Hom.: 256 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7539
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0495 AC: 7539AN: 152284Hom.: 256 Cov.: 32 AF XY: 0.0490 AC XY: 3647AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
7539
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
3647
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
547
AN:
41570
American (AMR)
AF:
AC:
724
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
120
AN:
3472
East Asian (EAS)
AF:
AC:
78
AN:
5182
South Asian (SAS)
AF:
AC:
181
AN:
4822
European-Finnish (FIN)
AF:
AC:
862
AN:
10612
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4889
AN:
68024
Other (OTH)
AF:
AC:
115
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
370
740
1110
1480
1850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
96
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.